Skip to main content

Table 3 Comparison of paraclinical variables before and after the intervention in the studied groups

From: Comparison of therapeutic effects of N-Acetylcysteine with pregabalin in improving the clinical symptoms of painful diabetic neuropathy: a randomized, double-blind clinical trial

Group

Time to intervention

Pregabalin

N-acetylcysteine

P-value

Variable

TAC (nmol/ ml)

Before

803.5±133.7

765±101.8

0.10

After

818.9±95.7

855.2±102.1

0.15

P- value

0.02

0.001

-

MDA (nmol/ ml)

Before

35.4±4.7

35.4±5.3

0.99

After

32.85±4.5

30.21±6.5

0.07

P- value

0.001

0.001

-

TTG (mM)

Before

343±39

346±50.2

0.72

After

344.5±41.5

355.2±47.2

0.34

P- value

0.25

0.04

-

NO (μM)

Before

66.8±3.62

66.8±3.7

0.97

After

64.45±3.5

63.47±3.95

0.30

P- value

0.001

0.001

-

CAT (munit/ ml)

Before

546.8±38.8

546.4±40.6

0.95

After

541.2±41.6

556.6±42.7

0.15

P- value

0.22

0.03

-